• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

UCSF Launches Observational Study Tracking Real-World Psychedelic Use in Thousands

by
November 14, 2026
in Health
Reading Time: 3 mins read
0
UCSF Launches Observational Study Tracking Real-World Psychedelic Use in Thousands

UCSF Launches Observational Study Tracking Real-World Psychedelic Use in Thousands

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Scientists at the University of California, San Francisco have initiated an expansive global research project known as CANOPY to investigate the biological and psychological effects of psychedelics in naturalistic, real-world environments. Recognizing that the vast majority of psychedelic experiences take place far outside formal academic laboratories, researchers designed the study to observe what these compounds do to human brains, bodies, and emotional well-being where consumption actually happens. The project intends to track as many as 3,000 individuals across the globe who are already planning to consume psychedelics at home, during organized retreats, or within other independent personal settings, allowing researchers to evaluate psychological changes at an unprecedented naturalistic scale.

Unlike conventional randomized clinical trials that supply pharmaceuticals and regulate experimental dosing schedules, the CANOPY project does not distribute substances or instruct volunteers to acquire or take any controlled drugs. Instead, the initiative operates as an observational, predominantly remote research study that registers adult participants who have already arranged their own psychedelic sessions.

The study evaluates an extensive spectrum of psychoactive and psychedelic substances commonly encountered outside clinical contexts, including psilocybin, lysergic acid diethylamide (LSD), ayahuasca, and ibogaine, along with MDMA and ketamine. Enrolled volunteers will complete a battery of standardized scientific assessments designed to measure psychological indicators, mood changes, and broader well-being.

Alongside widespread remote evaluations, the CANOPY protocol incorporates a comprehensive biological and physiological testing sub-study for a subset of participants able to travel to the UCSF campus. These individuals will undergo laboratory-based electroencephalography (EEG) and brain imaging, and they will supply blood and saliva samples prior to their scheduled psychedelic experiences.

Robin Carhart-Harris, PhD, a professor of neurology at UCSF and the lead investigator of CANOPY, noted that while existing scientific knowledge regarding psychedelics is derived primarily from tightly regulated laboratory settings, this trial applies systematic rigor to real-world experiences. Carhart-Harris explained that the goal is not merely to determine whether psychedelics can yield beneficial outcomes, but to understand for whom, under what specific circumstances, and through which mechanisms these outcomes occur. The team hopes the data will explain why individual responses vary dramatically and disentangle chemical drug actions from personal, biological, psychological, and environmental determinants.

The research is supported through federal funding from the Advanced Research Projects Agency for Health (ARPA-H), a division of the U.S. Department of Health and Human Services focusing on high-impact biomedical initiatives. CANOPY received an award of up to $1.4 million and represents one of three psychedelic studies at UCSF collectively awarded up to $8.5 million by ARPA-H. In parallel, Carhart-Harris is co-leading a $4 million project with Jennifer Mitchell, PhD, examining how psychological mindset and environmental setting impact psychedelic outcomes, while Mitchell and Lorenzo Pasquini, PhD, co-lead a third $3.1 million study investigating psychedelics in older adults exhibiting preclinical Alzheimer’s disease biomarkers.

Beyond its primary observational scope, CANOPY is architected as an overarching research platform intended to facilitate future targeted scientific investigations. Investigators anticipate that gathering granular observational data across thousands of self-directed experiences will provide critical safety and outcome benchmarks, helping scientists evaluate the potential risks and benefits of non-laboratory psychedelic use.

Researchers are currently recruiting adult participants who are already planning to use a psychedelic and are willing to complete the required research assessments for the project. Because the main study is conducted remotely, investigators do not supply participants with substances or instruct them to take drugs, and UCSF does not provide psychedelics or direct participants to obtain or use them. Individuals interested in enrolling can review detailed eligibility criteria, participation requirements, and enrollment information directly on the CANOPY study website.

The research is based at the University of California, San Francisco, an academic institution exclusively focused on the health sciences. UCSF is dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. UCSF Health, which serves as UCSF’s primary academic medical system, includes top-ranked specialty hospitals and other clinical programs, and has affiliations throughout the Bay Area. In addition to its primary Bay Area facilities, the UCSF School of Medicine also has a regional campus in Fresno.

Subject of Research: Large-scale observational study of real-world psychedelic drug use and biological outcomes

Article Title: UCSF launches large-scale study of psychedelics in the real world

Article References: UCSF launches large-scale study of psychedelics in the real world. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: UC San Francisco, CANOPY study, psychedelics, psilocybin, LSD, ayahuasca, ibogaine, MDMA, ketamine, Robin Carhart-Harris, ARPA-H, neuroimaging, electroencephalography, real-world evidence, wearable devices, biomarkers, psychological outcomes

News Source: Ophelia Keating. (November 14, 2026). UCSF Launches Observational Study Tracking Real-World Psychedelic Use in Thousands. Scienmag.

Tags: ARPA-HayahuascabiomarkersCANOPY studyelectroencephalographyibogaineketamineLSDMDMAneuroimagingpsilocybinPsychedelicspsychological outcomesReal-world evidenceRobin Carhart-HarrisUC San Franciscowearable devices
Share12Tweet7Share2ShareShareShare1

Related Posts

Altered Gut Microbes and Lipids Mark Early Brain Abnormalities in Preterm Hyperbilirubinemia

Altered Gut Microbes and Lipids Mark Early Brain Abnormalities in Preterm Hyperbilirubinemia

November 16, 2026
Problematic Smartphone Use Linked to Youth Distress in Comparative Study

Problematic Smartphone Use Linked to Youth Distress in Comparative Study

November 16, 2026

Global Meta-Analysis Reveals 5.5 Percent Nontuberculous Mycobacteria Prevalence in HIV Patients

November 16, 2026

Viewer Motivation and Presence Link to Danmaku Behaviour in Esports Survey

November 16, 2026

POPULAR NEWS

  • Chaotic Encryption Scheme Secures Sensitive Image Regions Using Blurring and Scrambling

    Chaotic Encryption Scheme Secures Sensitive Image Regions Using Blurring and Scrambling

    29 shares
    Share 12 Tweet 7
  • Problematic Smartphone Use Linked to Youth Distress in Comparative Study

    29 shares
    Share 12 Tweet 7
  • Dynamo Protocol Models Single-Cell Vector Fields to Predict Lineage Fate Transitions

    29 shares
    Share 12 Tweet 7
  • Global Meta-Analysis Reveals 5.5 Percent Nontuberculous Mycobacteria Prevalence in HIV Patients

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Altered Gut Microbes and Lipids Mark Early Brain Abnormalities in Preterm Hyperbilirubinemia

Artificial Intelligence Could Expand Carbon Credit Access for Smallholder Agrifood Systems

Fungal Enzyme Expression in Arabidopsis Reduces Cell Wall Recalcitrance and Bolsters Immunity

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 87 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.